Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Q4 2024 Earnings Call Transcript February 6, 2025 Société Générale SA beats earnings expectations. Reported EPS is $0.23, ...

National Bank Investments Inc. ("NBI") won ten awards at the Fundata 2024 FundGrade A+® Awards ceremony held on 6, 2025. These awards recognize Canadian investment funds that have maintained an ...

National Bureau of Investigation (NBI) operatives, armed with search warrants, successfully conducted multiple raids in ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

Drug charges were filed yesterday against five suspects for allegedly smuggling into the country more than 404 kilos of shabu ...

CEO Slawomir Krupa highlighted strong 2024 results, with revenues increasing 7%, surpassing the 5% target. Key drivers included GBIS, Ayvens, and International Retail, while French Retail experienced ...

Good day, everyone, and welcome to today's Neurocrine Biosciences reports Q4 and fiscal year 2024 Earnings Call. (Operator Instructions) Please note today's call will be recorded and I will be ...

"Huwag niyong tanggapin, huwag niyong iboto (Do not accept it, do not vote for them)," Commission on Elections (Comelec) ...

Investing.com -- Shares of Neurocrine (NASDAQ: NBIX) Biosciences (NASDAQ: NBIX) tumbled 11% as the company reported revenues that fell short of estimates. Despite reporting a 26% growth in INGREZZA® ...

Management guided INGREZZA sales to reach between $2.5 billion and $2.6 billion in 2025, supported by an expanded sales force and ongoing direct-to-consumer initiatives. This guidance reflects ...

The Council for the Welfare of Children (CWC) has underscored the urgent need for stronger child protection measures despite ...